StonvexLoading…
StonvexStonvexStonvexCore line items from LNSR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $11.75M | $51.66M | $37.32M | $24.57M |
Operating Income | $2.24M | $-24.58M | $-19.66M | $-12.08M |
Net Income | $36.33M | $-34.28M | $-32.82M | $-1.76M |
EPS (Diluted) | $0.00 | $-2.87 | $-2.75 | $-2.46 |
Total Assets | $66.22M | $71.43M | $70.20M | $70.41M |
Total Liabilities | $41.65M | $83.67M | $82.33M | $79.68M |
Cash & Equivalents | $12.49M | $12.97M | $7.64M | $7.15M |
Free Cash Flow OCF − CapEx | Not available | $-14.91M | $-15.53M | $-12.02M |
Shares Outstanding | 12.10M | 11.99M | 11.94M | 11.93M |